Relies on “virtual patients to avoid animal and human testing”
Virtonomy has raised €8.5M across 2 funding rounds from 9 investors, most recently a round in Dec 2025. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-12-10 | Other | €5.0M | Bayern Kapital,Companisto | View deal → |
| 2023-04-13 | Other | €3.5M | Accenture Ventures,Bayern Kapital,Dieter von Holtzbrinck Ventures (DvH Ventures),Honeystone Ventures,Initiative for Industrial Innovators,N&V Capital+2 more | View deal → |
